Bullous Pemphigoid: Symptoms, Causes and Treatment

Bullous pemphigoid is an autoimmune skin condition that most often affects older adults and can cause intense itching, redness, and tense blisters. With timely diagnosis and treatment, symptoms can usually be controlled and the skin can heal more comfortably.

Overview

Bullous pemphigoid is a blistering skin disease that happens when the body’s immune system mistakenly attacks structures that help the outer layers of skin stay attached. When that support weakens, fluid can collect under the skin and form tense blisters. The condition is most often seen in older adults, although the exact pattern varies from person to person.

In many cases, the first clue is not a blister at all. People may notice stubborn itching, irritated red patches, or areas that look like eczema or hives. Because the earlier signs can resemble other common skin problems, the diagnosis is sometimes delayed until the blisters become more obvious.

For international patients, the journey to care may begin with a dermatologist or primary doctor at home and continue with specialist evaluation abroad if the diagnosis is uncertain or symptoms are not improving. A clear diagnosis matters because treatment is tailored, and the right plan can reduce discomfort while protecting the skin from further damage.

Symptoms

The hallmark of bullous pemphigoid is a tense blister, meaning a blister that feels firm rather than fragile. These blisters can appear on the arms, legs, abdomen, groin, or in areas of friction. Some people have only a few blisters, while others develop more widespread lesions over time.

Before blisters appear, the skin may itch intensely. Red or urticarial-looking patches may appear first, and the itching can be persistent enough to disturb sleep or daily routines. In some patients, the skin becomes sore or inflamed even when blisters are not yet visible.

Common features may include:

• Itching that may come before blisters
• Tense, fluid-filled blisters
• Red, inflamed, or hive-like plaques
• Crusted or healing areas after blisters break
• Sensitivity or discomfort in affected skin

Unlike some other blistering disorders, the mouth is often not affected, though exceptions can occur. Because several skin conditions can look similar early on, a medical assessment is important rather than relying on appearance alone.

Causes & Risk Factors

Bullous pemphigoid is an autoimmune disease. That means the immune system, which normally helps defend the body, creates antibodies that mistakenly target proteins involved in holding the skin layers together. As a result, the layers separate and blisters form beneath the surface.

Doctors do not always find a single cause. In some people, the condition develops without a clear trigger. In others, it may be associated with certain medicines, existing illnesses, or changes in immune function. Age is one of the most important risk factors, and the condition is more common in older adults.

Factors that may be linked with a higher likelihood include:

• Older age
• Autoimmune tendencies or other immune-related conditions
• Neurologic disease in some patients
• Exposure to certain medicines in selected cases
• Skin irritation or friction that can worsen symptoms

It is helpful to remember that risk factors do not mean causation in every case. Many people with these risk factors never develop bullous pemphigoid, and many patients have no obvious trigger at all. The goal of evaluation is to identify the likely pattern and rule out other blistering diseases that need different treatment.

Diagnosis

Diagnosis usually begins with a careful review of the skin, symptoms, and medical history. A dermatologist may ask when the itching started, whether blisters come and go, what medications are being taken, and whether there are any other health conditions that could influence the rash. Photographs from the early stages can be useful if the skin has changed over time.

A skin biopsy is often the key test. One sample may be examined under a microscope to look at the pattern of blistering, and another may be used for direct immunofluorescence testing, which can detect immune deposits at the skin level. Blood tests may also be used in some cases to support the diagnosis or help with follow-up.

Because several blistering disorders can look similar, the diagnostic process is important even when symptoms seem straightforward. Accurate testing helps the care team choose the safest and most effective treatment, especially for patients who may be traveling internationally and need a clear plan for follow-up after returning home.

Treatment Options

Treatment is aimed at calming the immune reaction, healing the skin, and easing itching or discomfort. The exact plan depends on how widespread the disease is, the patient’s overall health, and how the skin responds over time. Some people need only limited therapy, while others require a more structured approach.

Topical corticosteroids are commonly used, especially when the disease is limited to certain areas. In more extensive cases, doctors may recommend systemic medicines that help suppress the immune response or reduce inflammation. The choice of therapy is individualized, because the balance between benefit and side effects matters, particularly in older adults.

Supportive measures are also important. Gentle wound care, protection against skin trauma, and management of itching can make a meaningful difference. If blisters become open or infected, the treatment plan may need to be adjusted.

Possible treatment approaches may include:

• Topical corticosteroid creams or ointments
• Oral anti-inflammatory or immunomodulating medicines
• Medicines used to reduce immune activity when needed
• Moisturizing and protective skin care
• Monitoring and treatment of secondary infection if it occurs

For patients who travel for care, it can help to leave with a written plan that explains how to use medicines, what side effects to watch for, and when to schedule follow-up. Coordinated care is especially useful when a condition may need monitoring over weeks or months rather than a single visit.

Prevention & Self-care

Bullous pemphigoid cannot always be prevented, but symptoms can often be made easier to manage with practical skin care. The skin should be treated gently, since friction and trauma can worsen blistering. Soft clothing, careful bathing habits, and avoiding vigorous scrubbing may reduce irritation.

Regular moisturizing can help protect the skin barrier and reduce dryness-related itching. Keeping nails short may lessen accidental scratching during sleep. Some people find that cool compresses provide temporary relief for itching, although these should be used gently and with guidance if the skin is very fragile.

Helpful self-care steps may include:

• Using mild, fragrance-free cleansers and moisturizers
• Avoiding tight clothing and rough fabrics
• Not popping blisters unless a clinician advises otherwise
• Watching for redness, warmth, swelling, or drainage that could suggest infection
• Taking medicines exactly as prescribed and reporting side effects promptly

When someone is receiving treatment away from home, self-care becomes part of continuity. Knowing how to protect the skin during flights, hotel stays, or long journeys can reduce flares and make recovery more comfortable between appointments.

When to See a Doctor

Medical evaluation is recommended if a person develops new blistering, especially when the blisters are tense, widespread, or preceded by persistent itching. It is also important to seek care if a rash that looked like eczema, hives, or irritation is not improving as expected. Early assessment can shorten the time to diagnosis and help prevent unnecessary skin breakdown.

Prompt review is especially important if blisters become painful, ooze, crust heavily, or show signs of infection. Fever, spreading redness, or a sudden change in overall health should also be assessed without delay. People with diabetes, frailty, or other long-term conditions may need closer monitoring because skin healing can be more complicated.

Anyone already diagnosed with bullous pemphigoid should contact a clinician if symptoms worsen, medicines cause troublesome side effects, or the skin stops responding to treatment. In selected cases, international patients may choose a specialized center for diagnosis or a second opinion; Acibadem Health Point notes that its multidisciplinary specialists and JCI-accredited hospitals diagnose and treat this condition for international patients.

Frequently asked questions

What does bullous pemphigoid look like at first?

It often starts with itching, red patches, or areas that resemble hives or eczema. The blisters may appear later, so the early phase can be easy to miss. A dermatologist can help distinguish it from more common rashes.

Is bullous pemphigoid contagious?

No, it is not contagious. It is an autoimmune condition, which means it comes from the immune system’s response rather than from an infection. People cannot catch it from someone else.

Can bullous pemphigoid go away on its own?

Some cases may improve over time, but it should not be left without medical review. Treatment can reduce itching, limit blistering, and lower the chance of skin complications. A doctor can also monitor for medication side effects and adjust the plan if needed.

What is the main test for bullous pemphigoid?

A skin biopsy is usually the most important test, often combined with special immunofluorescence testing. These studies help confirm the diagnosis and separate it from other blistering diseases. Blood tests may be added in some situations.

Does bullous pemphigoid affect the mouth?

It usually affects the skin rather than the mouth, although individual cases can vary. If mouth sores are present, they should still be assessed because they may suggest another diagnosis or a related issue. A doctor can determine the cause more accurately.

How long does treatment usually take?

Treatment length varies depending on how active the disease is and how the body responds. Some people improve gradually with topical therapy, while others need longer-term medication and follow-up. The aim is to control symptoms and then taper treatment safely under medical supervision.

References

• American Academy of Dermatology
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• National Organization for Rare Disorders
• DermNet

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Clinical referenceBullous PemphigoidAcibadem International — clinical encyclopedia